The document outlines seven principles of public life that should guide pharmaceutical leaders: 1. Selflessness - Pharma leaders should act solely in the interest of patients, prioritizing patient welfare over other interests. 2. Integrity - Pharma leaders should not offer financial or other obligations to medical professionals that could influence prescription decisions. 3. Objectivity - Pharma leaders should promote products based on independent scientific evidence, not irrational drug combinations.